However, relief does not translate into measurable improvements in visual task performance or tear film metrics ...

IV iron dextran is most cost-effective, yielding 19.26 QALYs compared with 19.10 QALYs for oral ferrous sulfate ...

The sBLA is supported by data from the phase 3 SURPASS-ET trial, as well as confirmatory data from the phase 2b EXCEED-ET trial.

Narcan Nasal Spray is an opioid antagonist that reverses the effects of opioids, including respiratory depression, sedation, and hypotension.

Manufacturers to remove suicidal ideation warnings from Saxenda, Wegovy, and Zepbound labels following a large-scale FDA safety investigation.

An extension was required to provide time to review additional data requested by the FDA to clarify sparsentan’s clinical benefit.

Internal FDA reviews examined in the JAMA study show that the agency repeatedly confirmed that mifepristone is safe. One analysis found that among 1.88 million patients who had used the drug in the US ...

HealthDay News — TV characters are more likely to receive cardiopulmonary resuscitation (CPR) than people in real life, according to a research letter published online January 12 in Circulation: ...

The FDA is expected to decide on treatments for allergic fungal rhinosinusitis, bipolar I disorder, Hunter syndrome, Leber hereditary optic neuropathy, ovarian cancer, and schizophrenia.

Higher rates of glaucoma therapy seen at increasing IOP levels, with cutoff of 22 mm Hg influencing clinician decision-making ...

Zycubo is a copper replacement therapy administered via subcutaneous injection to bypass impaired GI absorption in patients with Menkes disease.

New sBLA for efgartigimod alfa-fcab aims to expand treatment for seronegative gMG patients who currently have limited medical options.